About 8.6M results
IASLC: Ivonescimab vs Pembrolizumab as First-Line Treatment in …
Promising Anti-Tumor Activity and Safety of Ivonescimab in …
Ivonescimab Outperforms Pembrolizumab as Frontline Therapy in …
Ivonescimab outperforms pembrolizumab in study for first-line …
Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated …
Ivonescimab Tops Pembro in Advanced PD-L1-Positive NSCLC
Summit therapy beat Merck blockbuster Keytruda in late-stage …
Akeso Published First-Ever Efficacy Data for PD-1/VEGF ... - BioSpace
Ivonescimab Monotherapy Decisively Beats Pembrolizumab …
Ivonescimab combined with chemotherapy in patients with EGFR …